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the results of real time PCR and western blot demonstrated that
captopril signiﬁcantly downregulated the expression of apamin sen-
sitive SK channels (SK3 mRNA: CAF 2.10  0.9, n ¼ 6 vs HF 8.40  2.10,
n ¼ 6; SK3 protein: CAF 0.40  0.07, n ¼ 6 vs HF 0.56  0.09, n ¼ 6).
CONCLUSIONS Captopril signiﬁcantly downregulated the sensitivity
of SK channels to [Ca2þ]i and the SK3 channels expression in HF, and
reversed the SK channels remodeling.GW26-e1586
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OBJECTIVES AMP-activated protein kinase (AMPK) exerts inhibitory
effects on cardiac hypertrophy. However, the mechanism remains
unclear. The aim of the present study was to investigate the effects of
AMPK on angiotensin II (AngII) -induced proliferation of cardiac
ﬁbroblast and the mechanisms involved.
METHODS Proliferation of cardiac ﬁbroblast was induced by angio-
tensin II (AngII). Cardiac ﬁbroblasts were treated with the speciﬁc
AMPK activator 5-aminoimidazole-4-carboxamide ribonucleoside
(AICAR, 0.5 mmol/L) and the speciﬁc AMPK antagonist Compound C
(1 umol/L), and then stimulated with AngII (1 umol/L). Cell prolifera-
tion and the DNA synthesis were measured by MTT assay and EdU
incorporation assay. TGF-b1 and Smad2, 3, 4 mRNA and protein
expression was detected using Real-Time PCR and western blot
analysis.
RESULTS Activation of AMPK by AICAR could inhibit AngII-induced
proliferation of cardiac ﬁbroblasts, manifesting decreased DNA syn-
thesis and collagen production (P<0.05). Moreover, AngII signiﬁ-
cantly increased the mRNA and protein expression of TGF-b1 and
Smad2, 3, 4 (P<0.05). AMPK activation markedly reversed the
elevated TGF-b1 and Smad2, 3, 4 mRNA and protein levels (P<0.05).
Furthermore, Treatment of proliferated cardiac ﬁbroblasts with
Compound C blunted the effects of AMPK on proliferation of cardiac
ﬁbroblasts and changes to the TGF-b1/Smad pathway (P<0.05).
CONCLUSIONS AMPK activation could attenuate proliferation of
cardiac ﬁbroblast induced by AngII, which may be due to the inhibi-
tion of TGF-b1/Smad pathways.GW26-e4768
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OBJECTIVES Depressed angiogenesis due to ischemic injury leads to
myocardial infarction. Copper (Cu) is involved in angiogenesis and
ischemia causes copper loss in the heart. The present study was un-
dertaken to test the hypothesis that Cu supplementation improves
myocardial angiogenesis, leading to regression of myocardial ischemic
infarction in Rhesus monkey model.
METHODS Coronary artery ligation was used to produce myocardial
ischemia and the monkeys developed myocardial infarction 4 weeks
after ischemia. A newly developed ultrasound contrast microbubble
composed of Cu-albumin coated structure was used to speciﬁcally
deliver Cu into the infarct area. The treatment was performed twice a
week for 4 weeks.
RESULTS This procedure effectively increased Cu concentrations in
the infarct area and activated the angiogenesis factors including
vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1),
and other relevant factors. Along with these changes, myocardial
infarct size was signiﬁcantly decreased and the density of myocardial
microvessels was signiﬁcantly increased. In addition, cardiac function
was signiﬁcantly recovered, as evidenced by increased ejection fraction
(EF) values and decreased end-systolic volume (ESV) measured by
echocardiography.CONCLUSIONS This study thus demonstrated that Cu supplementa-
tion improved cardiac structural and functional recovery after
ischemic infarction.
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OBJECTIVES The atrioventricular node(AVN) plays a role in conducting
action potentials at an appropriate conduction velocity from atria to
ventricles. Its complex anatomical structures and functional longitudi-
nal dissociations are considered important in delayed conduction and
AVN reentrant tachycardia (AVNRT). Inferior nodal extensions(INE) are
part of the AVN. It is thought that these extensions may be involved in
slow-pathway conduction and are part of the underlying circuitry that
causes AVNRT. Some other conduction tissue shared the same origin
layers with AVN distribute around the two valve annulus. The retro-
aortic node deﬁned as the enlargement of this node-like tissue is located
on the right side of the atrium parallel with the aorta. The potential
electrophysiological function of these node-like tissues is still unknown.
Understanding their detail anatomical structure, histological features
and electrophysiological behavior are signiﬁcant to clear the complex
conduction characteristics of the AV junction.
METHODS Adult rats(n¼6), mice(n¼5) and rabbit(n¼5) were used.
Serial sections from the entire AV junction were obtained. Masson’s
trichrome stain was performed on AVN regions to assess for ﬁbrous
tissue. Three connexins(Cx) proteins including Cx43, Cx40 and Cx45
which dominate the electronic conduction of the heart and three main
ion channels(Nav1.5, Cav3.1 and HCN4) participating the depolariza-
tion of myocardial cell were immunohistochemically labeled. Serial
sections were used to reconstruct a 3D computational model of the
anatomy of the AV junction which display the different histological
features at different levels.
RESULTS There appears to be an anterior extension of the AVN which
connect retroaortic node and AVN. The anterior node extension
(ANE), compact node and INE express the same connexin isoforms.
Nav1.5 labeling was abundant in the atrial and ventricular myocar-
dium. Nav1.5 labeling presents at a reduced level in the compact node,
ANE and INE. Cav3.1 and HCN4 expression were mainly expressed in
the Nav1.5 reduced area. Further, connections between the atria and
inferior extension occur indirectly via small branches. However, this
was distinct from the connection pattern that we observed between
the atria and ANE, which was direct.
CONCLUSIONS We conclude that the retroaortic node connect with
ANE forming ANE which suggests there would be direct electric con-
duction between them. Characteristics of these structures are
conserved among various species including rat, mouse and rabbit as
we had proven. ANE, AVN and INE have nearly the same electronic
level and action potential level structure basic that highlight they
would have the same conduction properties, but there are different
connection patterns in atrium between them that suggests there
would be the subtle conduction velocity difference after accept the
impulse, which provide a new location and substrate of conduction
that may present new insights on mechanisms underlying normal AV
conduction and AVNRT.
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OBJECTIVES AVE 0991, the nonpeptide angiotensin-(1-7) (Ang-(1-7))
analog, is recognized as having beneﬁcial cardiovascular effects.
However, the mechanisms have not been fully elucidated. This study
was designed to investigate the effects of AVE 0991 on cardiac hy-
pertrophy and the mechanisms involved.
METHODS Mice were subjected to aortic banding (AB) to induce cardiac
hypertrophy. After treatment with AVE 0991 (20 mg$kg$day (-1)) for four
weeks, indices of cardiac hypertrophy and heart function were
measured by echocardiography, histological analyses and quantitative
